Last updated on November 2017

FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk


Brief description of study

FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk

Detailed Study Description

A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy in Patients with Clinically Evident Cardiovascular Disease.

Clinical Study Identifier: TX4880

Contact Investigators or Research Sites near you

Start Over

Cheryl Langer, RN / Kimberly ...

Holy Cross Jim Moran Heart and Vascular Research Institute
Fort Lauderdale, FL USA
  Connect »